Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Friday, December 15, 2006 | ENZO Biochem Raises $46.0 Million in Registered Direct Offering |
Monday, December 11, 2006 | ENZO Biochem Reports Improved First Quarter Financial Results |
Thursday, December 07, 2006 | Discussion of Fiscal 2007 First Quarter Results |
Thursday, November 30, 2006 | U.S. Court Of Appeals Allows ENZO Biochem Patent Infringement Suit to Proceed |
Wednesday, November 22, 2006 | Third Annual Life Sciences Conference |
Thursday, November 16, 2006 | Patent on Basic DNA Gel |
Monday, October 16, 2006 | ENZO Biochem Reports Results for Fiscal 2006 and Fourth Quarter |
Monday, October 16, 2006 | ENZO Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceutical Executive, President of Enzo Therapeutics Unit |
Friday, October 13, 2006 | ENZO Biochem Acquires License to Six Key RNA Amplification Patents Complementary Product Line Based On Technology to Be Offered In Conjunction with Existing Microarray Labeling Systems |
Friday, October 13, 2006 | Enzo Biochem Reports Favorable Markman Ruling in Federal Court Upholding Key Patent Claim Terms |
Thursday, October 12, 2006 | Notice of Teleconference |
Friday, October 06, 2006 | ENZO Biochem Clinical Labs Announces Expanded Regional Services Contract With United Healthcare Group |
Tuesday, September 19, 2006 | ENZO Biochem Announces Settlement with Sigma-Aldrich in Contract and Patent Litigation |
Friday, September 08, 2006 | ENZO Named Senior Party in U.S. Patent & Trademark Office Proceeding ENZO Granted Interferences for Key Nucleic Acid Detection Technology |
Tuesday, August 15, 2006 | ENZO Biochem Reports Long Term Retention of Antisense RNA In Phase I Study Of Hiv-1 Infected Subjects Updated Report to International Aids Conference Calls Results “Significant” |
Wednesday, July 19, 2006 | ENZO Biochem Announces Approval For Phase II Double-Blind Clinical Trial Of Egs21 For Non-Alcoholic Steatohepatitis (Nash) |
Press Details Wednesday, June 21, 2006 | ENZO Biochem, Inc., Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
Monday, June 12, 2006 | ENZO Biochem To Present At Needham & Company Fifth Annual Biotechnology Conference |
Friday, June 09, 2006 | Enzo Biochem Reports Results For Third Fiscal Quarter |
Thursday, June 08, 2006 | ENZO Biochem Appoints Carl W. Balezentis, Ph.D., President Of Enzo Life Sciences Subsidiary |
Thursday, June 08, 2006 | ENZO Biochem Schedules Teleconference To Discuss Third Quarter Results |
Tuesday, June 06, 2006 | ENZO Biochem Appoints Andrew R. Crescenzo Senior Vice President Of Finance |
Tuesday, May 23, 2006 | ENZO Biochem Announces Plans to Produce Single Copy DNA Probes That Could Open Door to More Effective Treatment of Genetic Diseases and Cancer |
Tuesday, March 14, 2006 | ENZO Biochem Initiates Phase II Trial Of Immunomodulatory Compound For Crohn’s Disease |
Monday, March 13, 2006 | ENZO Biochem Reports Second Quarter Results |
Friday, March 10, 2006 | Discussion of Fiscal 2006 Second Quarter Results |
Wednesday, March 01, 2006 | ENZO Receives Approval To Commence HIV Clinical Trial |
Tuesday, February 21, 2006 | ENZO Awarded Patent For Phosphate Labeling For DNA Diagnostic And Medical Research Products |
Friday, January 20, 2006 | ENZO Biochem 2006 Annual Meeting of Shareholders webcast link: |
Thursday, January 19, 2006 | ENZO Biochem Awarded Patent Covering Processes For Producing Therapeutic Proteins Or RNAs In Living Cells |
Thursday, January 19, 2006 | ENZO Biochem Shareholders Elect Three Directors At Annual Meeting |
Wednesday, January 18, 2006 | ENZO Biochem, Inc. Announces Webcast Of Annual Meeting |